← Eichor
Study identifier: NCT06771037 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of tAN® in Alcohol Withdrawal Management

Condition: Alcohol Withdrawal  ·  Sponsor: Erin Deneke

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This research study is being conducted to learn if Transcutaneous Auricular Neurostimulation (tAN®) may be effective in treating alcohol withdrawal syndrome. Transcutaneous Auricular Neurostimulation (tAN®) works by delivering small electrical stimulations to the Vagus and Trigeminal nerves. This study will be conducted over the course of five days. Participants will be enrolled within 24 hours of entering treatment for alcohol withdrawal management. A total of 60 individuals will be enrolled and randomly assigned to either active (treatment with the device + treatment as usual) or sham (treatment as usual) group. Data will be collected on alcohol craving, use of comfort medications, sleep, and mood.

This description comes directly from the study's public registry record.

Talk to the study team

Erin Deneke, Ph.D.  ·  610-743-6242  ·  edeneke@caron.org

Dean Stankoski, M.S.  ·  610-743-6224  ·  dstankoski@caron.org

Always discuss trial participation with your own doctor first.

Locations (1)

Caron Treatment CentersWernersville, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06771037